FLEXION THERAPEUTICS, INC.

(FLXN)
Delayed Nasdaq  -  11/18 04:00:00 pm EST
9.120 USD   -0.22%
03/28Renovacor Names New CFO
MT
2021Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
MT
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
SummaryQuotesChartsNewsRatingsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about FLEXION THERAPEUTICS, INC.
03/28Renovacor Names New CFO
MT
2021Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
MT
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021Northland Securities Downgrades Flexion Therapeutics to Market Perform From Outperform,..
MT
2021FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Ma..
AQ
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Composite Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Global BMI Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P TMI Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Biotechnology Index
CI
2021FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
2021Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Flexion Thera..
PR
2021SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its..
PR
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021FLEXION THERAPEUTICS : HC Wainwright Downgrades Flexion Therapeutics to Neutral From Buy, ..
MT
2021SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its..
PR
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021FLEXION THERAPEUTICS INVESTOR ALERT : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
2021FLEXION THERAPEUTICS : BMO Capital Downgrades Flexion Therapeutics to Market Perform Ratin..
MT
2021FLEXION THERAPEUTICS : Credit Suisse Downgrades Flexion Therapeutics to Neutral from Outpe..
MT
2021FLEXION THERAPEUTICS : Credit Suisse Downgrades Flexion Therapeutics to Neutral From Outpe..
MT
2021FLEXION THERAPEUTICS : Raymond James Downgrades Flexion Therapeutics to Market Perform Fro..
MT
2021FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Results of Operatio..
AQ
2021Health Care Stocks Sliding in Late Monday Trading
MT
2021SECTOR UPDATE : Health Care
MT
2021SHAREHOLDER ALERT : Ademi LLP investigates whether Flexion Therapeutics, Inc. has obtained..
PR
2021Top Midday Gainers
MT
2021FLEXION MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whether the S..
BU
2021Health Care Stocks Trade Lower Premarket Monday
MT
2021Wall Street Declines on Soaring Energy Prices
MT
2021FLEXION THERAPEUTICS : Agrees to Be Acquired by Pacira BioSciences; Shares Soar Pre-Bell
MT
2021Top Premarket Gainers
MT
2021Pacira adds non-opioid pain drugs with $427.5 million Flexion buy
RE
2021PACIRA BIOSCIENCES : to buy Flexion for $427.5 million
RE
2021FLEXION THERAPEUTICS : Reports Inducement Grants UnderáNasdaq Listing Rule 5635(c)(4)
GL
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Biotechnology Select Industry..
CI
2021Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Co..
GL
2021FLEXION THERAPEUTICS : to Present at the Wells Fargo 2021 Virtual Healthcare Conference
AQ
2021FLEXION THERAPEUTICS : Announces Inclusion of ZILRETTA in American Academy of Orthopaedic ..
AQ
2021Flexion Therapeutics to Present at the Wells Fargo 2021 Virtual Healthcare Conference
GL
2021FLEXION THERAPEUTICS : Announces Inclusion of ZILRETTA« in American Academy of Orthopaedic..
AQ
2021Flexion Therapeutics Announces Inclusion of ZILRETTA« in American Academy of Orthopaedi..
CI
2021FLEXION THERAPEUTICS : Expands Early Stage Study of Drug Candidate for Post-Operative Pain..
MT
2021FLEXION THERAPEUTICS : Announces Expansion of Phase 1b Trial Investigating FX301 for the M..
AQ
2021Flexion Therapeutics Announces Expansion of Phase 1B Trial Investigating Fx301 for the ..
CI
2021FLEXION THERAPEUTICS : Announces Publication of Results from Phase 2 Pharmacokinetics (PK)..
AQ
2021Flexion Therapeutics, Inc. Announces Publication of Results from Phase 2 Pharmacokineti..
CI
2021FLEXION THERAPEUTICS : Goldman Sachs Adjusts Price Target on Flexion Therapeutics to $6 Fr..
MT
2021FLEXION THERAPEUTICS : Needham Adjusts Flexion Therapeutics' Price Target to $18 From $20,..
MT
2021FLEXION THERAPEUTICS : Q2 2021 Commercial Metrics Overview - August 4, 2021
PU
2021FLEXION THERAPEUTICS : Reports Second-Quarter 2021 Financial Results and Recent Business H..
PU
2021FLEXION THERAPEUTICS : Q2 Earnings Snapshot
AQ
2021TRANSCRIPT : Flexion Therapeutics, Inc., Q2 2021 Earnings Call, Aug 04, 2021
CI
2021FLEXION THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
2021Flexion Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 3..
CI
2021FLEXION THERAPEUTICS : Earnings Flash (FLXN) FLEXION THERAPEUTICS Reports Q2 Revenue $28.2..
MT
2021FLEXION THERAPEUTICS : Reports Second-Quarter 2021 Financial Resultsáand Recent Business H..
AQ
2021Flexion Therapeutics, Inc. Reiterates Net Sales Guidance for the Full Year 2021
CI
2021FLEXION THERAPEUTICS : to Report Second-Quarter 2021 Financial Results on August 4, 2021
AQ
2021FLEXION THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
2021Flexion Therapeutics, Inc. Announces Resignation of Patrick Mahaffy as A Member and Cha..
CI
2021Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors
GL
2021Flexion Therapeutics, Inc. Announces Appointment of Utpal Koppikar to Board of Director..
CI
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
2021Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021FLEXION THERAPEUTICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021FLEXION THERAPEUTICS : Q1 Earnings Snapshot
AQ
2021Flexion Therapeutics to Present at the 2021 Raymond James Human Health Innovation Confe..
GL
2021FLEXION THERAPEUTICS : Names New Chief Medical Officer
MT
2021Flexion Therapeutics Announces Appointment of William T. Andrews, M.D., F.A.C.P., as Ch..
GL
2021Flexion Therapeutics, Inc. Appoints William T. Andrews as Chief Medical Officer, Effect..
CI
2021TRANSCRIPT : Flexion Therapeutics, Inc. Presents at Goldman Sachs 42nd Annual Global Healt..
CI
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
2021Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virt..
GL
1  2  3  4  5  6  7  8Next